FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Dall'Era

Research Profile

Disorders

Prostatic Neoplasms

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Marc A Dall'Era
The economics of active surveillance for prostate cancer.
Marc A Dall'Era; Stephen J Freedland; Laurence H Klotz; Christopher Parker; Peter C Albertsen; Christopher Bangma; Peter R Carroll; H Ballentine Carter; Matthew Cooperberg; Mark S Soloway
Active surveillance for prostate cancer: a systematic review of the literature.
Kirk A Keegan; Marc A Dall'Era; Blythe Durbin-Johnson; Christopher P Evans
Active surveillance for prostate cancer compared with immediate treatment: an economic analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Dall'Era (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marc A Dall'Era
The economics of active surveillance for prostate cancer.
Current opinion in urology 2013;23(3):278-82.
2012: Marc A Dall'Era; Stephen J Freedland; Laurence H Klotz; Christopher Parker; Peter C Albertsen; Christopher Bangma; Peter R Carroll; H Ballentine Carter; Matthew Cooperberg; Mark S Soloway
Active surveillance for prostate cancer: a systematic review of the literature.
European urology 2012;62(6):976-83.
2012: Kirk A Keegan; Marc A Dall'Era; Blythe Durbin-Johnson; Christopher P Evans
Active surveillance for prostate cancer compared with immediate treatment: an economic analysis.
Cancer 2012;118(14):3512-8.
2012: Marc A Dall'Era; Liang Cheng; Chong-Xian Pan
Contemporary management of muscle-invasive bladder cancer.
Expert review of anticancer therapy 2012;12(7):941-50.
2012: Sun Kim; Marc A Dall'Era; Christopher P Evans
Economic analysis of active surveillance for localized prostate cancer.
Current opinion in urology 2012;22(3):247-53.
2011: John P McGahan; Shaun Loh; Marc A Dall'Era; Christopher P Evans; Evan Fitzgerald; Theresa Koppie; Chin-Shang Li
Pretreatment imaging can be used to select imaging guidance, ultrasound alone versus CT plus ultrasound, for percutaneous renal radiofrequency ablation.
AJR. American journal of roentgenology 2011;197(5):1244-50.
2011: Marc A Dall'Era; Benjamin Davies; Kirsten Greene; Badrinath R Konety; Maxwell V Meng; Nannette Perez; Katsuto Shinohara; Jeffrey Simko; Janet E Cowan; Peter R Carroll
Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.
BJU international 2011;107(8):1232-7.
2011: J L Barton; Marc A Dall'Era; L Gensler; Timothy H McCalmont; L Pincus; N Richman; Jinoos Yazdany; Kenneth H Fye
Association of Sweet's Syndrome and Systemic Lupus Erythematosus.
Case reports in rheumatology 2011;2011():242681.
2010: Jennifer N Wu; Marc A Dall'Era
Active surveillance for localized prostate cancer--current practices and recommendations.
TheScientificWorldJournal 2010;10():2352-61.
2009: Benjamin J Davies; Marc C Smaldone; Natalia Sadetsky; Marc A Dall'Era; Peter R Carroll
The impact of obesity on overall and cancer specific survival in men with prostate cancer.
The Journal of urology 2009;182(1):112-7; discussion 117.
2009: Marc A Dall'Era; Peter R Carroll
Outcomes and follow-up strategies for patients on active surveillance.
Current opinion in urology 2009;19(3):258-62.
2009: Simon L Conti; Marc A Dall'Era; Vincent Fradet; Janet E Cowan; Jeff Simko; Peter R Carroll
Pathological outcomes of candidates for active surveillance of prostate cancer.
The Journal of urology 2009;181(4):1628-33; discussion 1633-4.
2009: Marc A Dall'Era; Nap Hosang; Badrinath R Konety; Janet E Cowan; Peter R Carroll
Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.
The Journal of urology 2009;181(4):1622-7; discussion 1627.
2008: Marc A Dall'Era; Badrinath R Konety; Janet E Cowan; Katsuto Shinohara; Frank Stauf; Matthew Cooperberg; Maxwell V Meng; Christopher J Kane; Nanette Perez; Viraj A Master; Peter R Carroll
Active surveillance for the management of prostate cancer in a contemporary cohort.
Cancer 2008;112(12):2664-70.
2008: Marc A Dall'Era; Christopher J Kane
Watchful waiting versus active surveillance: appropriate patient selection.
Current urology reports 2008;9(3):211-6.
2008: Marc A Dall'Era; Badrinath R Konety
Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression.
Nature clinical practice. Urology 2008;5(5):277-83.
2008: Marc A Dall'Era; Matthew Cooperberg; June M Chan; Benjamin J Davies; Peter C Albertsen; Laurence H Klotz; Christopher A Warlick; Lars Holmberg; Donald E Bailey; Meredith E Wallace; Philip W Kantoff; Peter R Carroll
Active surveillance for early-stage prostate cancer: review of the current literature.
Cancer 2008;112(8):1650-9.
2008: B N Breyer; Kirsten L Greene; Marc A Dall'Era; B J Davies; Christopher J Kane
Pelvic lymphadenectomy in prostate cancer.
Prostate cancer and prostatic diseases 2008;11(4):320-4.
2007: Thomas J Walsh; Marc A Dall'Era; Mary S Croughan; Peter R Carroll; Paul Turek
Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer.
The Journal of urology 2007;178(4 Pt 1):1440-6; discussion 1446.
2007: Marc A Dall'Era; Badrinath R Konety
The optimal management of clinically localized prostate cancer: the debate continues.
Nature clinical practice. Urology 2007;4(9):474-5.
2007: Marc A Dall'Era; Asa Oudes; Daniel B Martin; Alvin Y Liu
HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells.
The Prostate 2007;67(7):714-21.
2007: Marc A Dall'Era; Peter R Carroll
Prostate cancer--more information and more questions.
The Journal of urology 2007;177(5):1607-8.
2007: Marc A Dall'Era; Lawrence True; Andrew F Siegel; Michael P Porter; Tracy M Sherertz; Alvin Y Liu
Differential expression of CD10 in prostate cancer and its clinical implication.
BMC urology 2007;7():3.
2006: Marc A Dall'Era; Neil B Hampson; R Alex Hsi; Berit L Madsen; John M Corman
Hyperbaric oxygen therapy for radiation induced proctopathy in men treated for prostate cancer.
The Journal of urology 2006;176(1):87-90.
2005: Marc A Dall'Era; Pina M Cardarelli; Benjamin T Preston; A Witte; John C Davis
Type I interferon correlates with serological and clinical manifestations of SLE.
Annals of the rheumatic diseases 2005;64(12):1692-7.
2003: S-J Shih; Marc A Dall'Era; J R Westphal; J Yang; C G J Sweep; Regina Gandour-Edwards; Christopher P Evans
Elements regulating angiogenesis and correlative microvessel density in benign hyperplastic and malignant prostate tissue.
Prostate cancer and prostatic diseases 2003;6(2):131-7.
2001: Christopher P Evans; E C Stapp; Marc A Dall'Era; J Juarez; J C Yang
Regulation of u-PA gene expression in human prostate cancer.
International journal of cancer. Journal international du cancer 2001;94(3):390-5.
2000: Marc A Dall'Era; Sakti Das
Benign medullary fibroma of the kidney.
The Journal of urology 2000;164(6):2018.
1995: J. Stuart Wolf, Jr.; Michael L Cher; Marc A Dall'Era; Joseph C Presti; Hedvig Hricak; Peter R Carroll
The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy.
The Journal of urology 1995;153(3 Pt 2):993-9.